297 related articles for article (PubMed ID: 11423707)
1. Platelet function and fibrinolytic agents: two sides of a coin?
Callahan KP; Malinin AI; Gurbel PA; Alexander JH; Granger CB; Serebruany VL
Cardiology; 2001; 95(2):55-60. PubMed ID: 11423707
[TBL] [Abstract][Full Text] [Related]
2. Patency trials with reteplase (r-PA): what do they tell us?
Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
[TBL] [Abstract][Full Text] [Related]
3. [Development of new thrombolytic substances].
Zeymer U; Neuhaus KL
Herz; 1994 Dec; 19(6):314-25. PubMed ID: 7843688
[TBL] [Abstract][Full Text] [Related]
4. New developments in thrombolytic therapy.
Collen D; Gold HK
Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology of plasminogen activators: what are the clinical implications of drug design?
Smalling RW
Am J Cardiol; 1996 Dec; 78(12A):2-7. PubMed ID: 8990404
[TBL] [Abstract][Full Text] [Related]
6. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
7. Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: the Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy.
Serebruany VL; Malinin AI; Callahan KP; Binbrek A; Van De Werf F; Alexander JH; Granger CB; Gurbel PA;
Am Heart J; 2003 Apr; 145(4):636-42. PubMed ID: 12679759
[TBL] [Abstract][Full Text] [Related]
8. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
[TBL] [Abstract][Full Text] [Related]
9. [Increased efficacy of thrombolytic therapy in acute myocardial infarction by improved properties of new thrombolytic agents].
Huber K
Wien Klin Wochenschr; 2000 Sep; 112(17):742-8. PubMed ID: 11042902
[TBL] [Abstract][Full Text] [Related]
10. Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics.
Lancet; 1995 Aug; 346(8971):329-36. PubMed ID: 7623530
[TBL] [Abstract][Full Text] [Related]
11. Combinations of thrombolytic agents in acute myocardial infarction.
Bode C; Baumann H; von Hodenberg E; Freitag M; Nordt T
Z Kardiol; 1993; 82 Suppl 2():125-8. PubMed ID: 8328189
[TBL] [Abstract][Full Text] [Related]
12. [Experience with the thrombolytic therapy of myocardial infarct].
Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
[No Abstract] [Full Text] [Related]
13. Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase.
Moser M; Nordt T; Peter K; Ruef J; Kohler B; Schmittner M; Smalling R; Kübler W; Bode C
Circulation; 1999 Nov; 100(18):1858-64. PubMed ID: 10545429
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
15. Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction.
Noble S; McTavish D
Drugs; 1996 Oct; 52(4):589-605. PubMed ID: 8891469
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator.
Smalling RW
Eur Heart J; 1997 Dec; 18 Suppl F():F11-6. PubMed ID: 9447335
[TBL] [Abstract][Full Text] [Related]
17. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
18. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic therapy in acute myocardial infarction.
Hampton JR
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():241-6. PubMed ID: 9211016
[TBL] [Abstract][Full Text] [Related]
20. Coronary thrombolysis with clot-selective plasminogen activators.
Collen D; Bounameaux H
Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
